ABG Innovation Capital Partners III GP Ltd Portfolio
Auto-discovered active 13F filer.
SEC 13F CIK: 0001845297
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Q4 2023 · 3 positions · Total reported value $899.71K · Top-10 concentration 100.0% · Updated 2026-10-18
Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR
Turnover: 0.0% · 0 new · 0 cut · 0 exited
Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking
In its Q4 2023 13F filing, ABG Innovation Capital Partners III GP Ltd disclosed 3 equity positions with a combined reported value of $899.71K. The filing implies a focused portfolio: its ten largest positions account for 100.0% of reported value. HoldingsHub classifies the profile as Small / Focused / Health Tilt / Buy & Hold.
The largest disclosed positions as of Q4 2023 were CSTL ($793.00K), WHWK ($53.87K), SYBX ($52.85K). By sector, the heaviest allocations are Health Care 94.1%, Other 5.9%. Versus the prior quarter, allocation shifted toward Other (+0.6pp) and away from Health Care (-0.6pp).
Versus the prior quarter, ABG Innovation Capital Partners III GP Ltd opened 0 new positions, trimmed 0 and fully exited 0, a turnover rate of 0.0% of positions. The portfolio's overlap with the prior quarter was 100% of names.
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
Insider Transactions (Form 4)
Latest ABG Innovation Capital Partners III GP Ltd buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.
Fund Profile
ABG Innovation Capital Partners III GP Ltd files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q4 2025) lists 1 positions worth $64.53K in total. HoldingsHub carries 10 quarters of its filings (Q3 2023–Q4 2025).
Portfolio Structure
- 1 positions · $64.53K reported value (Q4 2025)
- Top 10 holdings = 100.0% of reported value
- Largest position: WHWK (WHITEHAWK THERAPEUTICS INC) at 100.0%
- Average position size: $64.53K
Sector Tilt
- Health Care 100.0%
- (classified holdings cover 100% of value)
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
FAQ
What did ABG Innovation Capital Partners III GP Ltd buy in 2023-Q4?
In its 2023-Q4 13F filing, ABG Innovation Capital Partners III GP Ltd reported 3 equity positions worth $899.71K in aggregate; its largest disclosed positions were CSTL ($793.00K), WHWK ($53.87K), SYBX ($52.85K).
How large is ABG Innovation Capital Partners III GP Ltd's portfolio?
ABG Innovation Capital Partners III GP Ltd reported $899.71K of long equity holdings across 3 positions as of 2023-Q4. Top-10 holdings account for 100.0% of reported value.
What is ABG Innovation Capital Partners III GP Ltd's investment style?
HoldingsHub classifies the portfolio as Small / Focused / Health Tilt / Buy & Hold, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.